As we head into the summer months, we want to take a moment to share some exciting updates from our team at Zelmic. New license We’ve reached two important milestones. We’ve obtained our MIA license, where we can help clients with imports from third countries, allowing us to manage global supply chains more efficiently and…
Continue ReadingIn the development of topical drug formulations, one of the greatest challenges is ensuring that in vitro (laboratory-based) tests accurately reflect how a drug will behave in vivo (on human skin). This is where In Vitro-In Vivo Correlation (IVIVC) plays a crucial role. A strong IVIVC allows pharmaceutical developers to predict drug absorption, efficacy, and…
Continue ReadingCenter for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.
Continue Reading